NAV

Fucose

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Fucose
DrugBank Accession Number
DB15236
Background

Fucose is under investigation in clinical trial NCT03354533 (Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II).

Type
Small Molecule
Groups
Investigational
Structure
3D
Similar Structures
Weight
Average: 164.157
Monoisotopic: 164.068473486
Chemical Formula
C6H12O5
Synonyms
  • L-FUCOSE
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
28RYY2IV3F
CAS number
2438-80-4
InChI Key
PNNNRSAQSRJVSB-KCDKBNATSA-N
InChI
InChI=1S/C6H12O5/c1-3(8)5(10)6(11)4(9)2-7/h2-6,8-11H,1H3/t3-,4+,5+,6-/m0/s1
IUPAC Name
(2S,3R,4R,5S)-2,3,4,5-tetrahydroxyhexanal
SMILES
C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C=O

References

General References
Not Available
Human Metabolome Database
HMDB0062489
ChemSpider
2299091
RxNav
2466731
ChEBI
48204
ZINC
ZINC000100015850
Wikipedia
Fucose

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3RecruitingTreatmentLeukocyte Adhesion Deficiency Syndrome1
1, 2CompletedTreatmentCongenital Disorder of Glycosylation IIc1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility258.0 mg/mLALOGPS
logP-2ALOGPS
logP-2.5Chemaxon
logS0.2ALOGPS
pKa (Strongest Acidic)12.31Chemaxon
pKa (Strongest Basic)-3Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count5Chemaxon
Hydrogen Donor Count4Chemaxon
Polar Surface Area97.99 Å2Chemaxon
Rotatable Bond Count4Chemaxon
Refractivity35.8 m3·mol-1Chemaxon
Polarizability15.22 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-05n1-9300000000-067ca5ef1dbdc796efe0
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-004i-2900000000-7beae0d1b67501fcb819
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0a4m-9300000000-d8665ec56300b843aef8
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0adi-9100000000-1352cae092fb635a679b
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-052e-9000000000-d4dc17807a67e32ab31f
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0005-9000000000-3aa9f6c350d846f38146
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-006y-9000000000-252ac3ef76a19fc26d87
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-137.6873684
predicted
DarkChem Lite v0.1.0
[M-H]-134.0783684
predicted
DarkChem Lite v0.1.0
[M-H]-135.0738
predicted
DeepCCS 1.0 (2019)
[M+H]+138.7138684
predicted
DarkChem Lite v0.1.0
[M+H]+136.2434684
predicted
DarkChem Lite v0.1.0
[M+H]+137.44273
predicted
DeepCCS 1.0 (2019)
[M+Na]+137.7093684
predicted
DarkChem Lite v0.1.0
[M+Na]+134.1415684
predicted
DarkChem Lite v0.1.0
[M+Na]+143.9229
predicted
DeepCCS 1.0 (2019)

Drug created at May 20, 2019 15:03 / Updated at June 12, 2020 16:53